Hair Loss or commonly known as Androgenic Alopecia has become a major concern for men and women alike, especially in the age group of 25 and above. Many doctors, clinicians, and cosmetologists have been investigating this problem for quite some time.
While non-surgical hair regrowth treatments like over-the-counter topical minoxidil, prescription oral finasteride, platelet-rich plasma (PRP) injections, and light and laser therapy treatments help reduce hair fall when used in combination, they sometimes leave adverse side effects.
Different types of hair-regrowth treatments available in the market have many limitations and they cannot revive hair beyond a certain stage.
Due to the Covid-19 pandemic, there has been a sharp rise in the number of temporary reversible hair loss cases in post-Covid patients due to physical and emotional stress. Hair fall post-Covid usually begins two or three months after the patient has recovered from it. The noticeable hair loss usually starts after almost 55 days post-recovery.
Hair loss happens due to fever because of infection, diet changes, stress due to isolation, and stress-related factors. This hair loss is known as Telogen Effluvium. This condition is a temporary form of hair loss and is often seen in Covid patients because of the shock that the body sustains resulting from fever and other symptoms.
Problems such as hair loss are fast emerging as one of the common side-effects of this pandemic, With just four sessions of the QR 678therapy, there is an increase in the density of existing hair follicles, offering significant coverage to the ones with hair loss. This research study has also been published in the Journal of Cosmetic Dermatology.